TR201714726A1 - Pharmaceutical formulation containing an anticholinergic active ingredient. - Google Patents
Pharmaceutical formulation containing an anticholinergic active ingredient. Download PDFInfo
- Publication number
- TR201714726A1 TR201714726A1 TR2017/14726A TR201714726A TR201714726A1 TR 201714726 A1 TR201714726 A1 TR 201714726A1 TR 2017/14726 A TR2017/14726 A TR 2017/14726A TR 201714726 A TR201714726 A TR 201714726A TR 201714726 A1 TR201714726 A1 TR 201714726A1
- Authority
- TR
- Turkey
- Prior art keywords
- active ingredient
- pharmaceutical formulation
- formulation containing
- anticholinergic active
- anticholinergic
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 title 1
- 230000001078 anti-cholinergic effect Effects 0.000 title 1
- 208000018569 Respiratory Tract disease Diseases 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- LERNTVKEWCAPOY-DZZGSBJMSA-N tiotropium Chemical compound O([C@H]1C[C@@H]2[N+]([C@H](C1)[C@@H]1[C@H]2O1)(C)C)C(=O)C(O)(C=1SC=CC=1)C1=CC=CS1 LERNTVKEWCAPOY-DZZGSBJMSA-N 0.000 abstract 1
- 229940110309 tiotropium Drugs 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Mevcut buluş solunum yolları hastalıklarının tedavisinde kullanılacak tiotropium içeren farmasötik formülasyonlara ve bu formülasyonların hazırlanma usullerine ilişkindir.The present invention relates to pharmaceutical formulations containing tiotropium to be used in the treatment of respiratory tract diseases and to methods of preparation of these formulations.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2017/14726A TR201714726A1 (en) | 2017-09-30 | 2017-09-30 | Pharmaceutical formulation containing an anticholinergic active ingredient. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2017/14726A TR201714726A1 (en) | 2017-09-30 | 2017-09-30 | Pharmaceutical formulation containing an anticholinergic active ingredient. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201714726A1 true TR201714726A1 (en) | 2019-04-22 |
Family
ID=67979844
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2017/14726A TR201714726A1 (en) | 2017-09-30 | 2017-09-30 | Pharmaceutical formulation containing an anticholinergic active ingredient. |
Country Status (1)
| Country | Link |
|---|---|
| TR (1) | TR201714726A1 (en) |
-
2017
- 2017-09-30 TR TR2017/14726A patent/TR201714726A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1120605T1 (en) | DRY POWDER PREPARATION INCLUDING A PHOSPHODIESTERATION INHIBITOR | |
| MA52257A (en) | PHARMACEUTICAL COMPOSITIONS CONSISTING OF BLAUTIA AND THEIR ORAL ADMINISTRATION | |
| TR201904455T4 (en) | 1,2,4-triazoles and their uses as nuclear transport modulators. | |
| WO2014176128A3 (en) | Compositions and methods for the therapy and diagnosis of influenza | |
| EA201590343A1 (en) | ALKYLPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND FURTHER DISEASES | |
| CU23923B1 (en) | POLYPEPTIDES DERIVED FROM IL-2 WITH AGONIST ACTIVITY | |
| MX2019003467A (en) | Formulations and methods for vaginal delivery of antiprogestins. | |
| MA40539A (en) | Methods for formulating antibody drug conjugate compositions | |
| EA201590667A1 (en) | ACYLAMINOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND OTHER DISEASES | |
| EA201591541A1 (en) | BETA SECRETASE INHIBITORS 1 (BACE 1) | |
| CY1123366T1 (en) | 8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES | |
| DOP2017000307A (en) | ORAL SOLID FORMULATION CONTAINING IRINOTECAN AND METHOD OF PREPARATION OF THE SAME. | |
| MX2017004772A (en) | Compositions and methods for physiological delivery using cannabidiol. | |
| MX2018012618A (en) | Oral pharmaceutical compositions of mesalazine. | |
| CY1122882T1 (en) | 3-(CARBOXYETHYL)-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES | |
| MX2018000262A (en) | Therapeutic uses of berberine formulations. | |
| MX2022013450A (en) | Pharmaceutical formulations. | |
| EA201592242A1 (en) | PYRIDON DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND OTHER DISEASES | |
| EA201892842A1 (en) | PHARMACEUTICAL COMPOSITIONS, INCLUDING SAFINAMID | |
| PH12019501820A1 (en) | Pharmaceutical compositions for combination therapy | |
| TR201714726A1 (en) | Pharmaceutical formulation containing an anticholinergic active ingredient. | |
| EA201590847A1 (en) | NEW ROCK INHIBITORS | |
| MX2020005921A (en) | Formulations and methods for vaginal delivery of antiprogestins. | |
| MA49148A (en) | PHARMACEUTICAL COMPOSITIONS CONSISTING OF DGLA ACID AND THEIR USE | |
| MX2016007881A (en) | Use of an ageratina pichinchensis extract for the treatment of the minor recurrent aphthous stomatitis. |